2 months Truist Financial Raises ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $62.00 MarketBeat
Truist Financial upped their price target on shares of ANI Pharmaceuticals from $60.00 to $62.00 and gave the stock a “hold” rating in a research note on Tuesday.
Nasdaq 100 · Pharmaceuticals · Science · Truist Financial Corp (TFC)
X